Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?

Lekuona I, Anguita M, Zamorano JL, Rodríguez JM, Barja de Soroa P, Pérez-Alcántara F.

Rev Esp Cardiol (Engl Ed). 2019 May;72(5):398-406. doi: 10.1016/j.rec.2018.03.024. Epub 2018 Jul 7. English, Spanish.

PMID:
31007166
2.

PCSK9 Inhibitors: From Innovation to Sustainable Clinical Application.

Lekuona I.

Rev Esp Cardiol (Engl Ed). 2018 Dec;71(12):996-998. doi: 10.1016/j.rec.2018.06.032. Epub 2018 Aug 24. English, Spanish. No abstract available.

PMID:
30150140
3.

Use of the cardiovascular polypill 40mg in secondary cardiovascular prevention.

Marzal D, Rodríguez Padial L, Arnáiz JA, Castro A, Cosín J, Lekuona I, Guijarro C.

Clin Investig Arterioscler. 2018 Sep - Oct;30(5):240-247. doi: 10.1016/j.arteri.2018.04.004. Epub 2018 Jul 17. Review. English, Spanish.

PMID:
30017176
4.

The Ideal Lipid Report: A Need for Consensus.

Pedro-Botet J, Rodríguez-Padial L, Brotons C, Esteban-Salán M, García-Lerín A, Pintó X, Lekuona I, Ordóñez-Llanos J.

Rev Esp Cardiol (Engl Ed). 2018 Jul;71(7):512-514. doi: 10.1016/j.rec.2018.04.003. Epub 2018 Apr 30. English, Spanish. No abstract available.

PMID:
29716842
5.

Homogenization of the lipid profile values.

Pedro-Botet J, Rodríguez-Padial L, Brotons C, Esteban-Salán M, García-Lerín A, Pintó X, Lekuona I, Ordóñez-Llanos J.

Clin Investig Arterioscler. 2018 Jan - Feb;30(1):36-48. doi: 10.1016/j.arteri.2017.12.001. Epub 2017 Dec 21. English, Spanish.

PMID:
29274683
6.

Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol.

Oyanguren J, García-Garrido L, Nebot Margalef M, Lekuona I, Comin-Colet J, Manito N, Roure J, Ruiz Rodriguez P, Enjuanes C, Latorre P, Torcal Laguna J, García-Gutiérrez S; ETIFIC7 research group.

ESC Heart Fail. 2017 Nov;4(4):507-519. doi: 10.1002/ehf2.12152. Epub 2017 Apr 3. Review.

7.

Is Edoxaban Cost-Effective For Non-Valvular Atrial Fibrillation Patients Treated With Vitamin K Antagonists In Spain?

Lekuona I, Anguita M, Zamorano JL, Barja P, Rodríguez JM, Pérez-Alcántara F.

Value Health. 2015 Nov;18(7):A392. doi: 10.1016/j.jval.2015.09.873. Epub 2015 Oct 20. No abstract available.

8.

Supervised exercise for acute coronary patients in primary care: a randomized clinical trial.

Ortega R, Garcia-Ortiz L, Torcal J, Echevarria P, Vargas-Machuca C, Gomez A, Salcedo F, Lekuona I, Montoya I, Grandes G; ESCAP Group.

Fam Pract. 2014 Feb;31(1):20-9. doi: 10.1093/fampra/cmt059. Epub 2013 Oct 19.

PMID:
24142481
9.

Patients with cardiac disease: Changes observed through last decade in out-patient clinics.

Cordero A, Bertomeu-Martínez V, Mazón P, Fácila L, Cosín J, Bertomeu-González V, Rodriguez M, Andrés E, Galve E, Lekuona I, González-Juanatey JR.

World J Cardiol. 2013 Aug 26;5(8):288-94. doi: 10.4330/wjc.v5.i8.288.

10.

Trends in clinical profile and medical treatments of atrial fibrillation patients over the last 10 years.

Rodríguez-Mañero M, Bertomeu-González V, Cordero A, Moreno-Arribas J, Mazón P, Fácila L, Cosín J, Galve E, Lekuona I, González-Juanatey JR, Bertomeu-Martínez V.

Rev Port Cardiol. 2013 Feb;32(2):103-9. doi: 10.1016/j.repc.2012.06.011. Epub 2013 Jan 20.

11.

Attitude and efficacy of cardiologists with respect to smoking in patients after acute coronary syndromes.

Cordero A, Bertomeu-Martínez V, Mazón P, Cosín J, Galve E, Lekuona I, de la Guía F, Gonzalez-Juanatey JR.

Rev Esp Cardiol (Engl Ed). 2012 Aug;65(8):719-25. Epub 2012 Jun 26. English, Spanish.

PMID:
22739551
12.

[Advances in arterial hypertension and diabetes mellitus].

Cordero A, Lekuona I, Galve E, Mazón P; Sección de Hipertensión Arterial, Grupo de Trabajo Corazón y Diabetes, Grupo de Trabajo Cardio-Renal, Sociedad Española de Cardiología, España.

Rev Esp Cardiol (Engl Ed). 2012 Jan;65 Suppl 1:12-23. doi: 10.1016/j.recesp.2011.10.030. Review. Spanish.

PMID:
22269836
13.

Impact of new criteria for anticoagulant treatment in atrial fibrillation.

Rodríguez-Mañero M, Cordero A, Bertomeu-González V, Moreno-Arribas J, Bertomeu-Martínez V, Mazón P, Fácila L, Cosín J, Lekuona I, Galve E, González-Juanatey JR.

Rev Esp Cardiol. 2011 Aug;64(8):649-53. doi: 10.1016/j.recesp.2011.03.014. Epub 2011 Jun 8. English, Spanish.

14.

[Factors associated with uncontrolled hypertension in patients with and without cardiovascular disease].

Cordero A, Bertomeu-Martínez V, Mazón P, Fácila L, Bertomeu-González V, Cosín J, Galve E, Núñez J, Lekuona I, González-Juanatey JR.

Rev Esp Cardiol. 2011 Jul;64(7):587-93. doi: 10.1016/j.recesp.2011.03.008. Epub 2011 Jun 2. Spanish.

15.

[Clinical features and hospital complications of patients with acute coronary syndromes according to smoking habits].

Cordero A, Bertomeu-Martínez V, Mazón P, Galve E, Lekuona I, de la Guía F, Cosín J, García Gómez J, Roncales F, González-Juanatey JR.

Med Clin (Barc). 2012 Apr 21;138(10):422-8. doi: 10.1016/j.medcli.2011.01.016. Epub 2011 Mar 31. Spanish.

PMID:
21453939
16.

Clustering of target organ damage increases mortality after acute coronary syndromes in patients with arterial hypertension.

Cordero A, Morillas P, Bertomeu-Gonzalez V, Quiles J, Mazón P, Guindo J, Soria F, Llácer A, Lekuona I, Gonzalez-Juanatey JR, Bertomeu V; Prevalence of Peripheral Arterial Disease in Patients with Acute Coronary Syndrome Investigators.

J Hum Hypertens. 2011 Oct;25(10):600-7. doi: 10.1038/jhh.2010.109. Epub 2010 Dec 16.

PMID:
21160527
17.

Short-term metabolic changes achieved by weight loss in hypertensive patients.

Cordero A, Bertomeu-Martínez V, Mazón P, Martín-Raymondi D, Palma JL, Anguita M, Lekuona I, Galve E, González-Juanatey JR.

Int J Cardiol. 2011 Dec 15;153(3):286-90. doi: 10.1016/j.ijcard.2010.08.051. Epub 2010 Sep 20.

PMID:
20851483
18.

Rationale and design of a randomised controlled trial evaluating the effectiveness of an exercise program to improve the quality of life of patients with heart failure in primary care: The EFICAR study protocol.

Zuazagoitia A, Grandes G, Torcal J, Lekuona I, Echevarria P, Gómez MA, Domingo M, de la Torre MM, Ramírez JI, Montoya I, Oyanguren J, Pinilla RO; EFICAR Group (Ejercicio Físico en la Insuficiencia Cardiaca).

BMC Public Health. 2010 Jan 25;10:33. doi: 10.1186/1471-2458-10-33.

19.

Usefulness of an abnormal ankle-brachial index for detecting multivessel coronary disease in patients with acute coronary syndrome.

Núñez D, Morillas P, Quiles J, Cordero A, Guindo J, Soria F, Mazón P, Lekuona I, Rodríguez-Padial L, Llácer A, González-Juanatey JR, Bertomeu V; PAMISCA study researchers.

Rev Esp Cardiol. 2010 Jan;63(1):54-9.

20.

Prevalence and prognostic influence of peripheral arterial disease in patients >or=40 years old admitted into hospital following an acute coronary event.

Bertomeu V, Morillas P, Gonzalez-Juanatey JR, Quiles J, Guindo J, Soria F, Llacer A, Lekuona I, Mazón P, Martín-Luengo C, Rodriguez-Padial L; Prevalence of Peripheral Arterial Disease in Patients with Acute Coronary Síndrome (PAMISCA) Investigators.

Eur J Vasc Endovasc Surg. 2008 Aug;36(2):189-96. doi: 10.1016/j.ejvs.2008.02.004. Epub 2008 Mar 28.

Supplemental Content

Loading ...
Support Center